HOME >> BIOLOGY >> NEWS
Turning the tables in chemistry

Waltham, MAWhat do glowing veggies have to do with a career in science" It just so happens that electrified pickles swimming in metal ions are one example of the type of undergraduate chemistry class demonstration that helps make a future in science a bright possibility, rather than a total turn-off, for many students.

In a commentary in this months Nature Chemical Biology, Brandeis University and Howard Hughes Medical Institute (HHMI) Professor Irving Epstein outlines a gathering storm clouding the future of U.S. science and prescribes a series of strategies to help avert a looming national crisis. Epstein says the continued success of U.S. science is seriously threatened by the fact that increasing numbers of undergraduates, particularly the disadvantaged, are writing off a career in science.

Why? Many students find introductory science, and chemistry in particular, both difficult and dull the way it is conventionally taught at the college level, discouraging many potential scientists before they ever have the chance to get hooked on science.

Anyone who teaches an introductory science course at one of this countrys elite universities is familiar with the sea of white faces he or she encounters, and the tendency of that ocean to whiten even more as the semester progresses and as one moves up the ladder of courses, writes Epstein, who last year won $1 million from HHMI to revamp introductory chemistry at Brandeis with an eye to luringand retainingmore students in science, particularly disadvantaged ones.

We need to ask ourselves why science is unattractive to so many students, particularly (but by no means exclusively), to underrepresented minority students, writes Epstein. He believes that conventional science teaching and passive learning are primary culprits, because they rely too heavily on lecturing as well as unrelated and unexciting laboratory experiments.

Epstein proposes a variety of strategies aimed at
'"/>

Contact: Laura Gardner
gardner@brandeis.edu
781-736-4204
Brandeis University
7-Jun-2007


Page: 1 2

Related biology news :

1. Turning a cellular sentinel into a cancer killer
2. Turning green into yellow
3. Turning sensation into perception
4. Turning viruses into allies against cancer
5. Food safety begins as vegetables grow
6. Researcher focuses on pros, cons of antioxidants from fruits and vegetables
7. Nutrients in certain vegetables may provide cancer-fighting benefit
8. Vegetables, like people, urged to live up to potential
9. Healthy fruits, vegetables highlight joint medical, agricultural research meet in Texas
10. Leafy green vegetables may help keep brains sharp through aging
11. Aloe vera coating may prolong freshness, safety of fruits and vegetables

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Turning the tables chemistry

(Date:6/23/2015)... GARDENS, Fla. , June 23, 2015 ... identity management and authentication solutions, today announced enhanced ... strong, multi-factor authentication solution.  The enhancements build ... use of the DigitalPersona Altus platform and ... reader compatibility. In today,s environment ...
(Date:6/17/2015)... GERMANTOWN, Maryland , June 17, 2015 /PRNewswire/ ...   Produktlinie mit DNA-Tests verbessert den Analyseprozess und senkt ... ; Frankfurt Prime Standard: QIA) hat heute in den ... Investigator ® für die ... neuen Kits zur Erstellung genetischer Fingerabdrücke bieten eine integrierte ...
(Date:6/17/2015)... BEACH GARDENS, Fla. , June 17, 2015 ... management solutions, today announced that its U.are.U ® ... Togo,s Eateries, Inc., a ... fast casual sandwich chain, to increase security, improve ... Crossmatch fingerprint readers enable instant, non-repudiable identity confirmation ...
Breaking Biology News(10 mins):Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 2QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 3QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 4QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 5QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 6Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 2Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 3
(Date:7/2/2015)... ... July 02, 2015 , ... ... of surgical instruments in Orthopedics, announced today the acquisition of Turner Medical, ... largest provider of surgical instruments to the Spine Industry. The acquisition of Turner ...
(Date:7/1/2015)... BURLINGTON, Mass. , July 1, 2015 /PRNewswire/ ... three most frequently cited advantages of Otezla are ... favorable safety profile, as reported by surveyed rheumatologists. ... and launched for the treatment of active psoriatic ... . The current standard of care includes conventional ...
(Date:7/1/2015)... July 1, 2015   Neuraltus Pharmaceuticals, Inc. ... of groundbreaking drugs to treat neurodegenerative diseases such ... Robert G. Miller , M.D., Director of the ... California Pacific Medical Center in San Francisco, has been ... $1.5 million to help fund a Phase 2 ...
(Date:7/1/2015)... ... July 01, 2015 , ... A newly launched business ... to lower the barriers to innovation in life sciences R&D. The Pistoia Alliance President’s ... cash prizes of US$15,000 and a period of expert mentorship from a senior industry ...
Breaking Biology Technology:In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 3Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Pistoia Alliance Launches Startup Challenge 2Pistoia Alliance Launches Startup Challenge 3
Cached News: